ASCO 2018 highlights: metastatic breast cancer.

Rinnerthaler, G, Gampenrieder, SP, Greil, R. MEMO-MAG EUR MED ONC. 2018, 11(4): 276-279.

The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.

Wolff, F, Leisch, M, Greil, R, Risch, A, Pleyer, L. Cell Commun Signal. 2017, 15(1):13.

Olaptesed pegol, an anti-CXCL12/SDF-1 Spiegelmer, alone and with bortezomib-dexamethasone in relapsed/refractory multiple myeloma: a Phase IIa Study.

Ludwig, H, Weisel, K, Petrucci, MT, Leleu, X, Cafro, AM, Garderet, L, Leitgeb, C, Foa, R, Greil, R, Yakoub-Agha, I, Zboralski, D, Vauleon, S, Duemmler, T, Beyer, D, Kruschinski, A, Riecke, K, Baumann, M, Engelhardt, M. Leukemia. 2017, 31(4):997-1000.

Milestones in Chronic Lymphocytic Leukemia: An exciting decade of progress-10th anniversary of memo.

Egle, A. Memo. 2017, 10(1):8-12.

Acute myeloid leukemia – strategies and challenges for targeting oncogenic Hedgehog/GLI signaling.

Aberger, F, Hutterer, E, Sternberg, C, Del Burgo, PJ, Hartmann, TN. Cell Commun Signal. 2017, 15(1): 8.

Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial.

Weiss, L, Melchardt, T, Egle, A, Hopfinger, G, Hackl, H, Greil, R, Barth, J, Rummel, M. Ann Hematol. 2017.

Amb a 1 isoforms: unequal siblings with distinct immunological features.

Wolf, M, Twaroch, TE, Huber, S, Reithofer, M, Steiner, M, Aglas, L, Hauser, M, Aloisi, I, Asam, C, Hofer, H, Parigiani, MA, Ebner, C, Bohle, B, Briza, P, Angela, N, Stolz, F, Jahn-Schmid, B, Wallner, M, Ferreira, F. Allergy. 2017.

The Human NADPH Oxidase, Nox4, Regulates Cytoskeletal Organization in Two Cancer Cell Lines, HepG2 and SH-SY5Y.

Auer, S, Rinnerthaler, M, Bischof, J, Streubel, MK, Breitenbach-Koller, H, Geisberger, R, Aigner, E, Cadamuro, J, Richter, K, Sopjani, M, Haschke-Becher, E, Felder, TK, Breitenbach, M. Front Oncol. 2017, 7:111.

Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence – A Phase II Study.

Eisterer, W, Piringer, G, De Vries, A, Ofner, D, Greil, R, Tschmelitsch, J, Samonigg, H, Solkner, L, Gnant, M, Thaler, J. Anticancer Res. 2017, 37(5):2683-2691.

T cell exhaustion: from pathophysiological basics to tumor immunotherapy.

Catakovic, K, Klieser, E, Neureiter, D, Geisberger, R. Cell Commun Signal. 2017, 15(1):.